Phase 1 Stem Cells Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Chronic PancreatitisMesenchymal Stem Cells
Medical University of South Carolina42 enrolled1 locationNCT05095532
Recruiting
Phase 1Phase 2
Treatment With Human Umbilical Cord-derived Mesenchymal Stromal Cells in Systemic Sclerosis
Mesenchymal Stem CellsSclerosis, Systemic
Marie Hudson, MD18 enrolled1 locationNCT04356287
Recruiting
Phase 1
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
EfficacySafetySpinal Cord Injury+4 more
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.12 enrolled1 locationNCT06976229
Recruiting
Phase 1Phase 2
HUC-MSC for Treatment of High-risk HPV Infection
Human Papillomavirus VirusesMesenchymal Stem Cells
Shanghai East Hospital60 enrolled1 locationNCT06610773
Completed
Phase 1
Epithelial cell transfer for severe corneal disease
Limbal stem cells deficiency
Inflammatory Diseases Research Unit, School of Medical Sciences, University of NSW30 enrolled1 locationACTRN12607000211460